July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Min-Han Tan Highlighted Medicare Coverage for LiquidHallmark ctDNA/ctRNA Liquid Biopsy
Jul 1, 2025, 19:06

Min-Han Tan Highlighted Medicare Coverage for LiquidHallmark ctDNA/ctRNA Liquid Biopsy

Min-Han Tan, Founder and CEO of Lucence, shared a post on LinkedIn by Mayo Clinic Laboratories, adding:

“ctDNA and ctRNA liquid biopsy is available now to help US cancer patients to help identify guideline recommended biomarkers.
LiquidHallmark ctDNA and ctRNA is the first such Medicare fully reimbursed test.
Very grateful to help advance liquid biopsy together with Mayo Clinic Laboratories!”

Quoting Mayo Clinic Laboratories’ post:

“Liquid biopsy cancer testing is designed to detect clinically relevant biomarkers in ctDNA and ctRNA.
Learn about patients who will benefit from the test and how an oncologist might use the results.”

Watch the video attached to this post.

More posts featuring Min-Han Tan on OncoDaily.